The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cell-Free Fetal DNA Testing Market Research Report 2024

Global Cell-Free Fetal DNA Testing Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885832

No of Pages : 85

Ask Your Query
Synopsis
Cell-free DNA screening is a test that can determine if a woman has a higher chance of having a fetus with Down syndrome (trisomy 21), trisomy 18, trisomy 13 or an abnormality in the sex chromosomes (X and Y chromosomes). With this test, a sample of the woman's blood is taken after 10 weeks of pregnancy.
The global Cell-Free Fetal DNA Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cell-Free Fetal DNA Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cell-Free Fetal DNA Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cell-Free Fetal DNA Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cell-Free Fetal DNA Testing include Roche, Arup Laboratories, PerkinElmer, Eurofins Biomnis, BGI, Berry Genomics, DAAN GENE, CapitalBio and Annoroad, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell-Free Fetal DNA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Free Fetal DNA Testing.
Report Scope
The Cell-Free Fetal DNA Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell-Free Fetal DNA Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Free Fetal DNA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Arup Laboratories
PerkinElmer
Eurofins Biomnis
BGI
Berry Genomics
DAAN GENE
CapitalBio
Annoroad
ADICON
KingMed
Segment by Type
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others
Segment by Application
Hospital
Clinic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Free Fetal DNA Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Abnormal Chromosome Number Detection
1.2.3 Gender Testing
1.2.4 Paternally Inherited Disorder Detection
1.2.5 Paternity Testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cell-Free Fetal DNA Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Free Fetal DNA Testing Market Perspective (2019-2030)
2.2 Cell-Free Fetal DNA Testing Growth Trends by Region
2.2.1 Global Cell-Free Fetal DNA Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell-Free Fetal DNA Testing Historic Market Size by Region (2019-2024)
2.2.3 Cell-Free Fetal DNA Testing Forecasted Market Size by Region (2025-2030)
2.3 Cell-Free Fetal DNA Testing Market Dynamics
2.3.1 Cell-Free Fetal DNA Testing Industry Trends
2.3.2 Cell-Free Fetal DNA Testing Market Drivers
2.3.3 Cell-Free Fetal DNA Testing Market Challenges
2.3.4 Cell-Free Fetal DNA Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Free Fetal DNA Testing Players by Revenue
3.1.1 Global Top Cell-Free Fetal DNA Testing Players by Revenue (2019-2024)
3.1.2 Global Cell-Free Fetal DNA Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cell-Free Fetal DNA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-Free Fetal DNA Testing Revenue
3.4 Global Cell-Free Fetal DNA Testing Market Concentration Ratio
3.4.1 Global Cell-Free Fetal DNA Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free Fetal DNA Testing Revenue in 2023
3.5 Cell-Free Fetal DNA Testing Key Players Head office and Area Served
3.6 Key Players Cell-Free Fetal DNA Testing Product Solution and Service
3.7 Date of Enter into Cell-Free Fetal DNA Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free Fetal DNA Testing Breakdown Data by Type
4.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Type (2019-2024)
4.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Type (2025-2030)
5 Cell-Free Fetal DNA Testing Breakdown Data by Application
5.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Application (2019-2024)
5.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell-Free Fetal DNA Testing Market Size (2019-2030)
6.2 North America Cell-Free Fetal DNA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell-Free Fetal DNA Testing Market Size by Country (2019-2024)
6.4 North America Cell-Free Fetal DNA Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Free Fetal DNA Testing Market Size (2019-2030)
7.2 Europe Cell-Free Fetal DNA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell-Free Fetal DNA Testing Market Size by Country (2019-2024)
7.4 Europe Cell-Free Fetal DNA Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free Fetal DNA Testing Market Size (2019-2030)
8.2 Asia-Pacific Cell-Free Fetal DNA Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Free Fetal DNA Testing Market Size (2019-2030)
9.2 Latin America Cell-Free Fetal DNA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell-Free Fetal DNA Testing Market Size by Country (2019-2024)
9.4 Latin America Cell-Free Fetal DNA Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free Fetal DNA Testing Market Size (2019-2030)
10.2 Middle East & Africa Cell-Free Fetal DNA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Cell-Free Fetal DNA Testing Introduction
11.1.4 Roche Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Arup Laboratories
11.2.1 Arup Laboratories Company Detail
11.2.2 Arup Laboratories Business Overview
11.2.3 Arup Laboratories Cell-Free Fetal DNA Testing Introduction
11.2.4 Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.2.5 Arup Laboratories Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Cell-Free Fetal DNA Testing Introduction
11.3.4 PerkinElmer Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.3.5 PerkinElmer Recent Development
11.4 Eurofins Biomnis
11.4.1 Eurofins Biomnis Company Detail
11.4.2 Eurofins Biomnis Business Overview
11.4.3 Eurofins Biomnis Cell-Free Fetal DNA Testing Introduction
11.4.4 Eurofins Biomnis Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.4.5 Eurofins Biomnis Recent Development
11.5 BGI
11.5.1 BGI Company Detail
11.5.2 BGI Business Overview
11.5.3 BGI Cell-Free Fetal DNA Testing Introduction
11.5.4 BGI Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.5.5 BGI Recent Development
11.6 Berry Genomics
11.6.1 Berry Genomics Company Detail
11.6.2 Berry Genomics Business Overview
11.6.3 Berry Genomics Cell-Free Fetal DNA Testing Introduction
11.6.4 Berry Genomics Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.6.5 Berry Genomics Recent Development
11.7 DAAN GENE
11.7.1 DAAN GENE Company Detail
11.7.2 DAAN GENE Business Overview
11.7.3 DAAN GENE Cell-Free Fetal DNA Testing Introduction
11.7.4 DAAN GENE Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.7.5 DAAN GENE Recent Development
11.8 CapitalBio
11.8.1 CapitalBio Company Detail
11.8.2 CapitalBio Business Overview
11.8.3 CapitalBio Cell-Free Fetal DNA Testing Introduction
11.8.4 CapitalBio Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.8.5 CapitalBio Recent Development
11.9 Annoroad
11.9.1 Annoroad Company Detail
11.9.2 Annoroad Business Overview
11.9.3 Annoroad Cell-Free Fetal DNA Testing Introduction
11.9.4 Annoroad Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.9.5 Annoroad Recent Development
11.10 ADICON
11.10.1 ADICON Company Detail
11.10.2 ADICON Business Overview
11.10.3 ADICON Cell-Free Fetal DNA Testing Introduction
11.10.4 ADICON Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.10.5 ADICON Recent Development
11.11 KingMed
11.11.1 KingMed Company Detail
11.11.2 KingMed Business Overview
11.11.3 KingMed Cell-Free Fetal DNA Testing Introduction
11.11.4 KingMed Revenue in Cell-Free Fetal DNA Testing Business (2019-2024)
11.11.5 KingMed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock